Aβ25-35 induces rapid lysis of red blood cells: Contrast with aβ1-42 and examination of underlying mechanisms

Brain Research

Volumn 771, Issue 1, 1997, Pages 147-153

  Mattson, Mark P ^a   Begley, James G ^a   Mark, Robert J ^a   Furukawa, Katsutoshi ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Calcium; Free radical; Ion current; Oxidative stress; Vascular amyloid

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT; CALCIUM ION; CONGO RED; ION CHANNEL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA PROTEIN (25 35); AMYLOID BETA-PROTEIN (1-42); AMYLOID BETA-PROTEIN (25-35); MEMBRANE LIPID; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD VESSEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CONTROLLED STUDY; HEMOLYSIS; HUMAN; HUMAN CELL; LIPID PEROXIDATION; NEUROTOXICITY; OXIDATIVE STRESS; PRIORITY JOURNAL; ADULT; BLOOD; COMPARATIVE STUDY; DRUG EFFECT; ERYTHROCYTE; IN VITRO STUDY; KINETICS; NERVE CELL; PATHOLOGY; PHYSIOLOGY; STRUCTURE ACTIVITY RELATION;

ADULT; AMYLOID BETA-PROTEIN; CONGO RED; ERYTHROCYTES; HEMOLYSIS; HUMANS; ION CHANNELS; KINETICS; LIPID PEROXIDATION; MEMBRANE LIPIDS; NEURONS; PEPTIDE FRAGMENTS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030609125     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00824-X     Document Type: Article

References (56)

1. Arispe N., Rojas E., Pollard H. Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. USA. 90:1993;567-571.
2. Arispe N., Pollard H., Rojas E. Giant multilevel cation channels formed by Alzheimer disease amyloid β-protein [AβP-(1-40)] in bilayer membranes. Proc. Natl. Acad. Sci. USA. 90:1993;10573-10577.
3. 2+ interaction with Alzheimer amyloid β protein calcium channels. Proc. Natl. Acad. Sci. USA. 93:1996;1710-1715.
4. Behl C., Davis J., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell. 77:1994;817-827.
5. Blanc E.M., Toborek M., Mark R.J., Hennig B., Mattson M.P. Amyloid β-peptide disrupts barrier and transport functions and induces apoptosis in vascular endothelial cells. J. Neurochem. 68:1997;1870-1881.
6. Blass J.P., Hanin I., Barclay L., Kopp U., Reding M.J. Red blood cell abnormalities in Alzheimer's disease. J. Am. Geriatr. Soc. 33:1985;401-405.
7. Bosman G.J., Bartholomeus I.G., de Man A.J., van Kalmthout P.J., de Grip W.J. Erythrocyte membrane characteristics indicate abnormal cellular aging in patients with Alzheimer's disease. Neurobiol. Aging. 12:1991;13-18.
8. 2+ influx induced by β-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation. J. Neurobiol. 26:1995;325-338.
9. Burdock D., Soreghan B., Kwon M., Kosmoski J., Knauer M., Henschen A., Yates J., Cotman C.W., Glabe C. Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J. Biol. Chem. 267:1992;546-554.
10. Butterfield D.A., Hensley K., Harris M., Mattson M.P., Carney J. β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200:1994;710-715.
11. Chen M., Inestrosa N.C., Ross G.S., Fernandez H.L. Platelets are the primary source of amyloid β-peptide in human blood. Biochem. Biophys. Res. Commun. 213:1995;96-103.
12. Davis-Salinas J., Saporito-Irwin S., Cotman C.W., Van Nostrand W. Amyloid β-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J. Neurochem. 65:1995;931-934.
13. Dianzani M.U., Poli G., Gravela E., Chiarpotto E., Albano E. Influence of lipid peroxidation on lipoprotein secretion by isolated hepatocytes. Lipids. 16:1981;823-829.
14. Eckert A., Hartmann H., Muller W. β-Amyloid protein enhances the mitogen-induced calcium response in circulating human lymphocytes. FEBS Lett. 330:1993;49-52.
15. Engstrom I., Ronquist G., Pettersson L., Waldenstrom A. Alzheimer amyloid β-peptides exhibit ionophore-like properties in human erythrocytes. Eur. J. Clin. Invest. 25:1995;471-476.
16. Evans P. Free radicals in brain metabolism and pathology. Br. Med. Bull. 49:1993;577-587.
17. Furukawa K., Abe Y., Akaike N. Amyloid β protein-induced irreversible current in rat cortical neurones. NeuroReport. 5:1994;2016-2018.
18. + channels and suppression of neuronal activity by secreted β-amyloid precursor protein. Nature. 379:1996;74-78.
19. Games D., Adams D., Alessandrinl R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagoplan S., Johnson-Wood K., Khan K., Lee M., Lelbowitz E., McConlogue S., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 373:1995;523-527.
20. Goodman Y., Mattson M.P. Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp. Neurol. 128:1994;1-12.
21. Goodman Y., Bruce A.J., Cheng B., Mattson M.P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem. 66:1996;1836-1844.
22. Gschwind M., Huber G. Apoptotic cell death induced by β-amyloid 1-42 peptide is cell type dependent. J. Neurochem. 65:1995;292-300.
23. Hajimohammadreza I., Brammer M.J., Eagger S., Burns A., Levy R. Platelet and erythrocyte membrane changes in Alzheimer's disease. Biochim. Biophys. Acta. 1025:1990;208-214.
24. Hall N.C., Carney J.M., Cheng M., Butterfield D.A. Prevention of ischemia/reperfusion-induced alterations in synaptosomal membrane-associated proteins and lipids by N-tert-butyl-α-phenylnitrone and difluoromethylornithine. Neuroscience. 69:1995;591-600.
25. Hoffeld J.T. Agents which block membrane lipid peroxidation enhance mouse spleen cell immune activities in vitro: relationship to the enhancing activity of 2-mercaptoethanol. Eur. J. Immunol. 11:1981;371-376.
26. Hsaio K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice. Science. 274:1996;99-103.
27. Kalaria R.N., Premkumar D.R.D., Pax A.B., Cohen D.L., Lieberburg I. Production and increased detection of amyloid β protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer's disease. Mol. Brain Res. 35:1996;58-68.
28. Keller J.N., Pang Z., Geddes J.W., Begley J.G., Germeyer A., Waeg G., Mattson M.P. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 69:1997;273-284.
29. Loo D.T., Copani A., Pike C.J., Whittemore E.R., Walencewicz A.J., Cotman C.W. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA. 90:1993;7951-7955.
30. Lorenzo A., Yankner B.A. β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA. 91:1994;12243-12247.
31. 2+ homeostasis and cell death. J. Neurosci. 15:1995;6239-6249.
32. Mark R.J., Lovell M.A., Markesbery W.R., Uchida K., Mattson M.P. A role for 4-hydroxynonenal in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68:1996;255-264.
33. Mark R.J., Pang Z., Geddes J.W., Mattson M.P. Amyloid β-peptide impairs glucose uptake in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J. Neurosci. 17:1997;1046-1054.
34. Markesbery W.R., Leung P.K., Butterfield D.A. Spin label and biochemical studies of erythrocyte membranes in Alzheimer's disease. J. Neurol. Sci. 45:1980;323-330.
35. Mason R.P., Estermyer J.D., Kelly J.F., Mason P.E. Alzheimer's disease amyloid β peptide 25-35 is localized in the hydrocarbon core: X-ray diffraction analysis. Biochem. Biophys. Res. Commun. 222:1996;78-82.
36. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R.E. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:1992;379-389.
37. Mattson M.P., Tomaselli K., Rydel R.E. Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res. 621:1993;35-49.
38. M.P. Mattson, K. Furukawa, A.J. Bruce, R.J. Mark, E.M. Blanc, Calcium homeostasis and free radical metabolism as convergence points in the pathophysiology of dementia, in: W. Wasco, R.E. Tanzi (Eds.), Molecular Mechanisms of Dementia, Humana Press, Clifton, NJ, 1996, pp. 103-143.
39. Mullan M., Crawford F. Genetic and molecular advances in Alzheimer's disease. Trends Neurosci. 16:1993;398-403.
40. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13:1993;1676-1687.
41. Raff M.C., Barres B.A., Burne J.F., Coles H.S., Ishizaki Y., Jacobson M.D. Programmed cell death and the control of cell survival. Phil. Trans. R. Soc. London B Biol. Sci. 345:1994;265-268.
42. + pump ATPase of human red blood cell membranes. Biochem. Pharmacol. 46:1993;525-534.
43. Selkoe D.J. Biochemistry of altered brain proteins in Alzheimer's disease. Annu. Rev. Neurosci. 12:1989;463-490.
44. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C., McCormack R., Wolfert R., Selkoe D., Lieberburg I., Schenk D. Isolation and quantitation of soluble Alzheimer's β-peptide from biological fluids. Nature. 359:1992;325-327.
45. Shearman M.S., Ragan C.I., Iversen L.L. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proc. Natl. Acad. Sci. USA. 91:1994;1470-1474.
46. Smith M.A., Sayre L.M., Monnier V.M., Perry G. Radical ageing in Alzheimer's disease. Trends Neurosci. 18:1995;172-176.
47. R. Subramaniam, F. Roediger, M.P. Mattson, J.N. Keller, G. Waeg, D.A. Butterfield, The lipid peroxidation product 4-hydroxy-2-trans-nonenal alters conformation of cortical synaptosomal membrane proteins, J. Neurochem. (1997) in press.
48. Tamaoka A., Kalaria R.N., Lieberburg I., Selkoe D.J. Identification of a stable fragment of the Alzheimer amyloid precursor containing the β-protein in brain microvessels. Proc. Natl. Acad. Sci. USA. 89:1992;1345-1349.
49. Thomas T., Thomas G., McLendon C., Sutton T., Mullan M. β-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature. 380:1996;168-171.
50. Wang J., Huang C.-J., Chow C.K. Red cell vitamin E and oxidative damage: a dual role of reducing agents. Free Radic. Res. 24:1996;291-298.
51. 2+ channel blockers attenuate β-amyloid peptide toxicity to cortical neurons in culture. J. Neurochem. 62:1994;372-375.
52. Wu J., Anwyl R., Rowan M.J. β-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus. NeuroReport. 6:1995;2409-2413.
53. Yankner B.A., Duffy L., Kirschner D. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science. 250:1990;279-282.
54. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 16:1996;921-932.
55. Zhou Y., Richardson J.S., Mombourquette M.J., Weil J.A. Free radical formation in autopsy samples of Alzheimer and control cortex. Neurosci. Lett. 195:1995;89-92.
56. Zhou Y., Gopalakrishnan V., Richardson J.S. Actions of neurotoxic β-amyloid on calcium homeostasis and viability of PC12 cells are blocked by antioxidants but not by calcium channel antagonists. J. Neurochem. 67:1996;1419-1425.